Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors Susan J. HinesJulie S. LitzGeoffrey W. Krystal OriginalPaper Pages: 1 - 10
BRCA1 mutation testing for Japanese patients with ovarian cancer in breast cancer screening Yoichiro YamashitaTadashi SagawaSeiichiro Fujimoto OriginalPaper Pages: 11 - 17
Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesions Maresa AltomonteEster FonsattiMichele Maio OriginalPaper Pages: 19 - 23
p73 mutations are not detected in sporadic and hereditary breast cancer David I. SchwartzNoralane M. LindorFergus J. Couch OriginalPaper Pages: 25 - 29
Policy guidelines for the utilization of formalin-fixed, paraffin-embedded tissue sections: the UNC SPORE experience L.G. DresslerJ. GeradtsB. Newman OriginalPaper Pages: 31 - 39
Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family Søren S. LarsenMikala EgebladAnne E. Lykkesfeldt OriginalPaper Pages: 41 - 56
Local signals induce CCAAT/enhancer binding protein-δ (C/EBP-δ) and C/EBP-β mRNA expression in the involuting mouse mammary gland Andrew P. GigliottiJames W. DeWille OriginalPaper Pages: 57 - 63
Telomerase activity in ductal carcinoma in situ of the breast B. ShpitzS. ZimlichmanA.pitz Klein OriginalPaper Pages: 65 - 69
Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus conventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice D. ArndtR. ZeisigA. Fahr OriginalPaper Pages: 71 - 80
